a,se_a,p_a,b,se_b,p_b,indirect,indirect_CI_lower,indirect_CI_upper,total_effect,direct_effect,n_snps_XM,n_snps_MY,cancer,mediator,indirect (95% CI),proportion mediated
-0.11311516624976789,0.013289891228492189,0.0,0.0023155988714342835,1.754390041428014e-05,0.0,-0.0002619293513100639,-0.00030206018406151326,-0.00019964038882596657,-0.0052271939897451155,-0.004965264638435052,28,6812279,LUAD,lymphocyte,-0.000262 (-0.000302–-0.000200),5.0
-0.13027371550197028,0.01720121664175505,3.6415315207705135e-14,0.0023155988714342835,1.754390041428014e-05,0.0,-0.0003016616685939133,-0.0003527210973188578,-0.00022608802347703636,-0.006149059363311944,-0.00584739769471803,23,6812279,LUSC,lymphocyte,-0.000302 (-0.000353–-0.000226),4.9
